Published in J Immunol on January 01, 1991
Regulation of immune responses by prostaglandin E2. J Immunol (2012) 3.93
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med (1995) 2.98
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev (1996) 2.77
Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med (2009) 2.68
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology (1996) 2.65
Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest (1995) 2.59
Human and animal dirofilariasis: the emergence of a zoonotic mosaic. Clin Microbiol Rev (2012) 2.57
Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut (1997) 2.35
Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol (1994) 2.08
Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun (2004) 2.04
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood (2005) 2.01
Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest (2001) 1.99
Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci U S A (1994) 1.89
Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res (1993) 1.80
IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med (2005) 1.76
Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun (2001) 1.76
Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun (1997) 1.72
Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun (2008) 1.66
Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun (2003) 1.55
Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study. Thorax (2008) 1.45
Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev (2003) 1.45
Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta (2009) 1.44
Paracoccidioides brasiliensis interferes on dendritic cells maturation by inhibiting PGE2 production. PLoS One (2015) 1.41
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol (2006) 1.40
Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun (2002) 1.39
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology (2002) 1.36
RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J (1995) 1.34
Sympathetic modulation of immunity: relevance to disease. Cell Immunol (2008) 1.33
Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol (2008) 1.30
Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol (2012) 1.29
Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity (2012) 1.28
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. J Clin Invest (1999) 1.25
Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun (2004) 1.24
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells. Blood (2010) 1.23
Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med (1994) 1.21
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid (2008) 1.21
Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol (2008) 1.19
Prostaglandin E2 and T cells: friends or foes? Immunol Cell Biol (2011) 1.12
Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol (2005) 1.10
Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol (2002) 1.09
Poxvirus-induced alteration of arachidonate metabolism. Proc Natl Acad Sci U S A (1993) 1.07
In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease. Gut (1997) 1.05
In vitro production of interleukin-4 and interferon-gamma by lymph node cells from BALB/c mice infested with nymphal Ixodes ricinus ticks. Immunology (1995) 1.05
Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression. Infect Immun (2007) 1.04
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity. Breast Cancer Res (2013) 1.04
Characterization of prostaglandin E2 production by Candida albicans. Infect Immun (2007) 1.04
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03
Bovine herpesvirus 4 is tropic for bovine endometrial cells and modulates endocrine function. Reproduction (2007) 1.03
Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J Gastroenterol (2004) 1.02
Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology (1997) 1.02
A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br J Pharmacol (2010) 1.01
Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis. Br J Pharmacol (1995) 1.00
Protease-activated receptors and prostaglandins in inflammatory lung disease. Br J Pharmacol (2009) 1.00
Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc Natl Acad Sci U S A (2003) 0.99
Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J Exp Med (2007) 0.99
Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Infect Immun (2001) 0.99
Antigen-presenting cell function during Plasmodium yoelii infection. Infect Immun (2002) 0.99
Purification and characterization of prostaglandin-H E-isomerase, a sigma-class glutathione S-transferase, from Ascaridia galli. Biochem J (1996) 0.98
Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling. J Biol Chem (2011) 0.98
Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs. Mediators Inflamm (2012) 0.97
Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection. J Virol (2011) 0.97
Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus. Immunology (2000) 0.96
The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS One (2012) 0.96
Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med (1991) 0.96
Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J Cardiovasc Pharmacol (2012) 0.96
Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol (2007) 0.95
A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J Clin Invest (1998) 0.94
The Th1/Th2-like switch in syphilitic infection: is it detrimental? Infect Immun (1992) 0.93
Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation. Infect Immun (1995) 0.93
Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step. J Virol (2004) 0.92
Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells. J Allergy Clin Immunol (2013) 0.92
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells. Blood (2005) 0.91
Immunosuppression and cytokine production in mice infested with Ixodes ricinus ticks: a possible role of laminin and interleukin-10 on the in vitro responsiveness of lymphocytes to mitogens. Immunology (1996) 0.89
Early life precursors, epigenetics, and the development of food allergy. Semin Immunopathol (2012) 0.89
Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin Exp Immunol (2002) 0.89
Prostaglandin E₂ promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase. Nat Commun (2013) 0.89
Entamoeba histolytica alters arachidonic acid metabolism in macrophages in vitro and in vivo. Immunology (1992) 0.88
Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One (2010) 0.88
CD14 and NFAT mediate lipopolysaccharide-induced skin edema formation in mice. J Clin Invest (2012) 0.88
Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation. J Biol Chem (2010) 0.88
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. Oncoimmunology (2015) 0.88
Differential regulation of cytokine production by nitric oxide. Immunology (1993) 0.87
PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing. PPAR Res (2012) 0.87
Proinflammatory and immunoregulatory roles of eicosanoids in T cells. Front Immunol (2013) 0.87
Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection. J Cell Mol Med (2008) 0.87
The role of prostaglandins in allergic lung inflammation and asthma. Expert Rev Respir Med (2014) 0.87
Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT. Blood Cancer J (2014) 0.87
Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J Virol (2004) 0.86
Proposed mechanisms of transfusion-induced immunomodulation. Clin Diagn Lab Immunol (1999) 0.86
Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study. J Lipid Res (2009) 0.86
Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells. Cell Mol Life Sci (2006) 0.86
Cyclic AMP-induced chromatin changes support the NFATc-mediated recruitment of GATA-3 to the interleukin 5 promoter. J Biol Chem (2008) 0.86
Impact of cAMP on the T-cell response to type II collagen. Immunology (2004) 0.85
Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells. Br J Pharmacol (2003) 0.85
Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc Natl Acad Sci U S A (1995) 0.85
Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy. Clin Exp Immunol (2010) 0.85
Prostaglandin E2 induction during mouse adenovirus type 1 respiratory infection regulates inflammatory mediator generation but does not affect viral pathogenesis. PLoS One (2013) 0.85
Prostaglandin E(2) in tick saliva regulates macrophage cell migration and cytokine profile. Parasit Vectors (2013) 0.84
Aspirin and decreased adult-onset asthma: randomized comparisons from the physicians' health study. Am J Respir Crit Care Med (2006) 0.84
Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology (Berl) (2000) 1.83
Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J Immunol (1995) 1.58
Regulation and development of cytochrome c-specific IL-4-producing T cells. J Immunol (1990) 1.55
Mercuric reductase: homology to glutathione reductase and lipoamide dehydrogenase. Iodoacetamide alkylation and sequence of the active site peptide. Biochemistry (1983) 1.26
Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Psychopharmacology (Berl) (2001) 1.19
Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens. J Immunol (1987) 1.18
Aged T cells are hyporesponsive to costimulation mediated by CD28. J Immunol (1994) 1.15
Functional analysis of the interaction of the antigen-specific T cell receptor with its ligands. J Immunol (1986) 1.11
Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res (1999) 1.10
Cytokine production by T lymphocytes from young and aged mice. J Immunol (1996) 1.01
The use of hydrophobic, alpha-helix-defined peptides in delineating the T cell determinant for pigeon cytochrome c. J Immunol (1987) 0.93
Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone. Int Immunol (1996) 0.88
Optimization of antigen presentation to T cell hybridomas by purified Ia molecules in planar membranes. Ia molecule polymorphism determines the antigenic fine specificity of the response to cytochrome c peptides. J Immunol Methods (1987) 0.88
Quantitative analysis of the T cell response to antigen and planar membranes containing purified Ia molecules. J Immunol (1987) 0.85
An age-related decrease in rescue from T cell death following costimulation mediated by CD28. Cell Immunol (1996) 0.85
A transcribed emergency record at minimum cost. Ann Emerg Med (1983) 0.80
CD4+ class I-restricted T cells specific for HIV gp160 315-329. Cell Immunol (1994) 0.79
Autologous fat injection and breast augmentation. Med J Aust (1988) 0.77
Hypoiodous acid as guest molecule in protonated water clusters: a combined FT-ICR/DFT study of I(H2O)n+. J Am Chem Soc (2001) 0.77
Pattern of lectin binding to murine T lymphocytes. Immunology (1992) 0.76
Use of a receptor competition assay to explore the interaction of the T cell antigen-specific receptor with its ligands. Fed Proc (1987) 0.75
Immunization of mice with human immunodeficiency virus glycoprotein gp160 peptide 315-329 induces both class I- and class II-restricted T cells: not all T cells can respond to whole molecule stimulation. AIDS Res Hum Retroviruses (1993) 0.75